June 2020


IT-DED³ Newsletter - Edition 1


Interview with Dr. Michael E. Stern about COVID-19

IT-DEDhas the honor of launching its first newsletter with an exclusive interview with Dr. Michael E. Stern, Chief Scientific Officer of ImmunEyez LLC and Head of the IT-DED³ External Advisory Board. Based on his extensive research trajectory, Dr. Stern shares his opinions and thoughts on the impact of COVID-19 on Dry Eye patients and ongoing research.

Read the full interview

OcuTher & IT-DED³ Meeting at EVER 2019

What a successful joint Seminar between OcuTher and IT-DED³! The seminar was organised as a satellite meeting to the EVER Congress 2019 in Nice, and it served as a first step towards a promising collaboration between the two ITN networks. The programme included outstanding presentations in the fields of Retinal and Dry Eye Disease treatment.

Access to article and presentations

Secondment stories: Asif visits Heidelberg

Md Asif Khan Setu, our ESR11, is currently a Visiting Researcher at Heidelberg Engineering GmbH, where he arrived in September 2019 to conduct a secondment until June 2020. He shares his experiences being a team member of this global leader in imaging and healthcare IT technologies for ophthalmic diagnostic instruments.

Discover more about the secondment

Get to know our partners

The Quinze-Vingts (XV-XX) National Ophthalmology Hospital is a reference centre for the development of ophthalmological clinical trials. For IT-DED³, it is a true privilege to have the opportunity to collaborate with a leader in research, treatment development and technological innovations for the benefit of visually impaired patients.

Read the complete article


Congratulations to Maha Abdallah, our ESR12, for her first published peer-reviewed article as a PhD student in the IT-DED³ team. This paper is published in the Carbohydrate Polymers Journal, with Open Access: 'Hyaluronic acid and Chondroitin sulfate from marine and terrestrial sources: extraction and purification methods'.

Publications of IT-DED³